Sodium Valproate (VPA) CAS 1069-66-5 API Factory High Purity

Tsanangudzo Pfupi

Kemikari Zita: Sodium Valproate (VPA)

Mazwi akafanana: Valproic Acid Sodium Munyu

CAS: 1069-66-5

Chitarisiko: Chichena kana Chinenge Chichena Crystalline Powder, Hygroscopic

Chiyero: 98.5% ~ 101.0% (Titration)

A Broad-Spectrum Anti-Epileptic Drug Kazhinji Inoshivirirwa Zvakanaka

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Tsanangudzo:

Mugadziri Wekutengesa Kwekutengesa ane Kuchena Kwepamusoro uye Hunhu Hwakagadzikana
Kemikari Zita: Sodium Valproate (VPA)
CAS: 1069-66-5

Chemical Properties:

Chemical Name Sodium Valproate
Mashoko anoreva zvakafanana VPA;Valproic Acid Sodium Munyu;Sodium 2-Propylpentanoate
Nhamba yeCAS 1069-66-5
Nhamba yeCAT RF-API14
Stock Status MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula C8H15NaO2
Molecular Weight 166.20
Melting Point 300 ℃
Density 1.0803 g/cm3
Mvura Solubility Soluble mumvura
Shipping Condition Under Ambient Temperature
Brand Ruifu Chemical

Zvinotsanangurwa:

Item Zvinotsanangurwa
Chitarisiko Ichena kana Inenge Yakachena Crystalline Powder, Hygroscopic
Identification Infrared Spectrum
Ne RT kuenzanisa
Maitiro eSodium Munyu
Solubility Yakanyanya Soluble Mumvura, Yemahara Soluble muEthanol
Acidity kana alkalinity Maererano neEP Criterions
Kujeka & Rudzi rweKugadzirisa Maererano neEP Criterions
Heavy Metals ≤20ppm
Sulfates ≤200ppm
Chloride ≤200ppm
Kurasika paKuomesa ≤2.0%
Chero Kusachena ≤0.10% (GC)
Zvose Zvisina Kuchena ≤0.30% (GC)
Assay 98.5% ~ 101.0% (Titration)
Test Standard European Pharmacopeia (EP)
Usage Active Pharmaceutical Ingredient (API)

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, Cardboard dhiramu, 25kg/Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza, mwando uye tumbuyu.

Zvakanakira:

1

FAQ:

12

Application:

Sodium Valproate (CAS: 1069-66-5) is anticonvulsant uye inoshanda mumiririri wekudzora zvese kusipo uye kunyanya generalized tonic-clonic seizures.Valproic acid sodium munyu (Sodium Valproate) inonzi histone deacetylase (HDAC) inhibitor, ine IC50 muhuwandu hwe0.5 uye 2 mM, inodzivisawo HDAC1 (IC50, 400 μM), uye inokonzera kuparara kweproteasomal yeHDAC2.Valproic acid sodium munyu inomutsa Notch1 kusaina uye inodzivirira kuwanda mudiki cell kenza yemapapu (SCLC) masero.Sodium Valproate (CAS: 1069-66-5) inoshandiswa mukurapa kwepfari, bipolar disorder uye kudzivirira migraine misoro.

Nyora meseji yako pano uye titumire kwatiri